Psilocybin and Subjective Experience Study
Treatments studied
Part of Injuries & trauma clinical trials.
This study looks at how psilocybin affects people's subjective experience. It aims to understand the mind-altering effects of this psychedelic compound in healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Be able to read and write in English
- No current or past psychiatric conditions like depression, anxiety, bipolar disorder, or psychosis
- No family history of schizophrenia or bipolar disorder in close relatives
- Not taking certain medications like antidepressants (SSRIs, SNRIs, MAO inhibitors) or antipsychotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
This trial tests how psilocybin affects the way people share and process a film experience. It aims to understand if the drug changes social connection or emotional response.
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.
Hear when a new Investigating the Importance of the Subjective Psychedelic Experience trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.